Antiphospholipid syndrome, also known as APS, is an autoimmune disease that sits at the intersection of inflammation and blood clotting. Antiphospholipid syndrome is best known for increasing the risk ...

10x Genomics, Inc. (NASDAQ:TXG) Q4 2025 Earnings Call Transcript February 12, 2026 10x Genomics, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.19. Operator: Thank you ...

A newly identified protein may hold the key to rejuvenating aging brain cells. Researchers found that boosting DMTF1 can ...

In a new study, an aging clock has revealed neuron-specific aging, as well as potentially neuroprotective compounds.

Antiphospholipid syndrome, also known as APS, is an autoimmune disease that sits at the intersection of inflammation and blood ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $166 million. The company expects the full year’s ...

HONG KONG, Feb. 13, 2026 /PRNewswire/ -- Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ ...

From molecular chaperones to mitochondrial failure, discover how heat reshapes the human transcriptome and drives the biological cascade that links rising temperatures to organ injury and public ...

For the first time, scientists have identified genetic variants that increase the risk of aneuploidy, in which cells have an ...

New genetics research reshapes dyslexia understanding. Find out more about how brain networks influence reading difficulties ...

SeekGene, a biotechnology company focused on "driving the development and democratization of innovative single-cell technologies", announced it has officially joined the Human Cell Atlas (HCA) ...